Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's disease.
about
Rapid antidepressant actions of scopolamine: Role of medial prefrontal cortex and M1-subtype muscarinic acetylcholine receptorsTargeting selective activation of M(1) for the treatment of Alzheimer's disease: further chemical optimization and pharmacological characterization of the M(1) positive allosteric modulator ML169.All muscarinic acetylcholine receptors (M1-M5) are expressed in murine brain microvascular endothelium.KV7 Channels Regulate Firing during Synaptic Integration in GABAergic Striatal Neurons.Endocannabinoid-dopamine interactions in striatal synaptic plasticity.Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditionsNovel allosteric agonists of M1 muscarinic acetylcholine receptors induce brain region-specific responses that correspond with behavioral effects in animal modelsParkinson's Disease and Its Management: Part 3: Nondopaminergic and Nonpharmacological Treatment Options.Molecular, Neurochemical, and Behavioral Hallmarks of Reserpine as a Model for Parkinson's Disease: New Perspectives to a Long-Standing Model.Regulation of neuronal communication by G protein-coupled receptors.Chemical modification of the M(1) agonist VU0364572 reveals molecular switches in pharmacology and a bitopic binding mode.Cholinergic and Dopaminergic Alterations in Nigrostriatal Neurons Are Involved in Environmental Enrichment Motor Protection in a Mouse Model of Parkinson's Disease.Effects of M1 and M4 activation on excitatory synaptic transmission in CA1.Parkinsonism Driven by Antipsychotics Originates from Dopaminergic Control of Striatal Cholinergic Interneurons.Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: role of M1 muscarinic receptors.Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine.Synthesis of novel and functionally selective non-competitive muscarinic antagonists as chemical probes.M1 muscarinic activation induces long-lasting increase in intrinsic excitability of striatal projection neurons.Basal Ganglia Neuromodulation Over Multiple Temporal and Structural Scales-Simulations of Direct Pathway MSNs Investigate the Fast Onset of Dopaminergic Effects and Predict the Role of Kv4.2.Relationship between muscarinic M1 receptor binding and cognition in medication-free subjects with psychosis.In silico studies targeting G-protein coupled receptors for drug research against Parkinson's disease.Novel long-acting antagonists of muscarinic ACh receptors.The striatal cholinergic system in L-dopa-induced dyskinesias.Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M4 Muscarinic Receptor.Using evolutionary tools to search for novel psychoactive plantsSugar Addiction: From Evolution to Revolution
P2860
Q27308009-A56E4D33-2B0F-4739-A43E-85E4B8A193F4Q30446914-B9954B40-29C9-49F3-BE7A-6D6B0AEF7E7FQ33895150-AB645DD4-B233-4C53-9A9C-C6BD1E69512BQ35737653-7C633114-03C4-465E-A1C4-1E7D5E78E037Q35898412-C6D479C9-AE24-43F2-9266-780FEECE653FQ36042479-000C1148-5519-4994-A6BE-C7FD047EBE71Q36099440-BA4DBBD0-CB69-4021-9064-211B7E4B2212Q36164724-BCA51526-90AE-4F0E-A850-D66AAE7B919DQ38366271-70BF1DFD-BBB6-4D06-A279-60A329C68971Q38484504-F1B8DB42-CC82-4C93-93DC-B80D4B540090Q39222571-2A42A7AC-E5B2-4CF1-B822-3F9219DBE66FQ39359668-403EBE19-678D-4B57-A830-001E8A432501Q41540365-C855E2FC-485A-46F6-A13C-890621CD3E4BQ41831385-3D6C8092-E98D-46F7-94A2-A56CDE04C570Q42971243-F039F01D-5C98-4444-8621-BAF897CAA98BQ47814036-D2CD4759-1296-4B72-85C7-FEEB0642E330Q48226745-DE711CF3-8D67-468B-9015-72849A259C22Q48248520-1E712991-4639-4BB1-85BE-D0AB263FA496Q50141308-D58C84E7-6CD3-49A2-AF79-BF966D08DC4DQ52645804-8670226B-C6C7-4D90-ACAB-708A580C59E2Q52665081-1068BA22-D1B7-4A58-BCD1-91297314ABC0Q52677740-13B488D5-B13D-4438-A207-1B556006A630Q52680310-65E26DAA-0F56-445D-9BF9-594E86280D00Q52740407-E7D9CB35-1973-4112-AE2E-177EF3B9CABCQ57429531-17C62130-8545-4E4C-80C6-F1B3C3F98E1AQ59134991-55928D02-9FF7-429C-A7D1-D71534D5FBAF
P2860
Roles of the M1 muscarinic acetylcholine receptor subtype in the regulation of basal ganglia function and implications for the treatment of Parkinson's disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Roles of the M1 muscarinic ace ...... atment of Parkinson's disease.
@ast
Roles of the M1 muscarinic ace ...... atment of Parkinson's disease.
@en
type
label
Roles of the M1 muscarinic ace ...... atment of Parkinson's disease.
@ast
Roles of the M1 muscarinic ace ...... atment of Parkinson's disease.
@en
prefLabel
Roles of the M1 muscarinic ace ...... atment of Parkinson's disease.
@ast
Roles of the M1 muscarinic ace ...... atment of Parkinson's disease.
@en
P2860
P50
P356
P1476
Roles of the M1 muscarinic ace ...... eatment of Parkinson's disease
@en
P2093
Analisa D Thompson
Carrie K Jones
P2860
P304
P356
10.1124/JPET.111.187856
P407
P577
2011-12-01T00:00:00Z